The Heart Institute of Japan Candesartan Randomized trial for Evaluation in Coronary Artery Disease

Trial Profile

The Heart Institute of Japan Candesartan Randomized trial for Evaluation in Coronary Artery Disease

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Nov 2013

At a glance

  • Drugs Candesartan cilexetil (Primary) ; Antihypertensives
  • Indications Cardiovascular disorders; Coronary artery disease; Essential hypertension; Hypertension
  • Focus Therapeutic Use
  • Acronyms HIJ-CREATE
  • Most Recent Events

    • 20 Nov 2013 Results of an analysis in patients with chronic kidney disease presented at the 86th Annual Scientific Sessions of the American Heart Association.
    • 29 Aug 2012 Substudy results comparing diabetic and non-diabetic cohorts presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.
    • 06 Jul 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top